GUIDING USE OF ONCOLOGY THERAPEUTICS

Magellan Bioanalytics has developed a proprietary assay and AI software aimed building a database of oncology patients, treatments and outcomes, and associated biomarkers.  at identifying biomarker profiles that predict patient response to immunotherapy (IO), making sure patients receive the right treatment and minimizing waste of healthcare resources.

© 2018 by Magellan Bioanalytics